Free Trial

Hawkins, Inc. (NASDAQ:HWKN) Shares Acquired by Royce & Associates LP

Hawkins logo with Basic Materials background

Key Points

  • Royce & Associates LP increased its stake in Hawkins, Inc. by 8.3% during the first quarter, now owning approximately $12.16 million worth of shares.
  • Hawkins reported $0.78 earnings per share for its latest quarter, exceeding analyst estimates of $0.74, with revenues of $245.32 million.
  • Institutional investors own 69.71% of Hawkins's stock, indicating a strong interest in the company's financial performance and stability.
  • Looking to export and analyze Hawkins data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Royce & Associates LP raised its holdings in Hawkins, Inc. (NASDAQ:HWKN - Free Report) by 8.3% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 114,812 shares of the specialty chemicals company's stock after acquiring an additional 8,785 shares during the period. Royce & Associates LP owned approximately 0.55% of Hawkins worth $12,161,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of HWKN. Wasatch Advisors LP acquired a new stake in shares of Hawkins during the 4th quarter worth approximately $42,466,000. Vaughan Nelson Investment Management L.P. increased its holdings in shares of Hawkins by 37.6% during the 1st quarter. Vaughan Nelson Investment Management L.P. now owns 350,722 shares of the specialty chemicals company's stock worth $37,148,000 after buying an additional 95,885 shares during the last quarter. Bessemer Group Inc. increased its holdings in shares of Hawkins by 157,110.0% during the 1st quarter. Bessemer Group Inc. now owns 94,326 shares of the specialty chemicals company's stock worth $9,991,000 after buying an additional 94,266 shares during the last quarter. Cerity Partners LLC increased its holdings in shares of Hawkins by 900.2% during the 4th quarter. Cerity Partners LLC now owns 82,576 shares of the specialty chemicals company's stock worth $10,166,000 after buying an additional 74,320 shares during the last quarter. Finally, Millennium Management LLC increased its holdings in shares of Hawkins by 291.5% during the 4th quarter. Millennium Management LLC now owns 86,100 shares of the specialty chemicals company's stock worth $10,562,000 after buying an additional 64,110 shares during the last quarter. Institutional investors and hedge funds own 69.71% of the company's stock.

Hawkins Stock Performance

NASDAQ HWKN traded down $1.22 during trading hours on Tuesday, hitting $159.63. The company had a trading volume of 14,220 shares, compared to its average volume of 146,702. The business has a 50 day moving average of $143.54 and a 200-day moving average of $123.39. The company has a market cap of $3.33 billion, a PE ratio of 39.51, a price-to-earnings-growth ratio of 2.70 and a beta of 0.85. Hawkins, Inc. has a 1-year low of $98.30 and a 1-year high of $165.87. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.37 and a current ratio of 2.15.

Hawkins (NASDAQ:HWKN - Get Free Report) last issued its quarterly earnings data on Wednesday, May 14th. The specialty chemicals company reported $0.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.74 by $0.04. The company had revenue of $245.32 million for the quarter, compared to analyst estimates of $230.69 million. Hawkins had a return on equity of 18.93% and a net margin of 8.66%. As a group, equities research analysts expect that Hawkins, Inc. will post 4 EPS for the current year.

Hawkins Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Friday, May 30th were paid a $0.18 dividend. The ex-dividend date was Friday, May 30th. This represents a $0.72 dividend on an annualized basis and a yield of 0.45%. Hawkins's dividend payout ratio is presently 17.82%.

Analyst Upgrades and Downgrades

HWKN has been the subject of a number of recent analyst reports. Wall Street Zen downgraded shares of Hawkins from a "buy" rating to a "hold" rating in a report on Saturday, July 5th. BWS Financial reiterated a "buy" rating and issued a $160.00 target price on shares of Hawkins in a report on Thursday, May 15th. Raymond James Financial assumed coverage on shares of Hawkins in a report on Thursday, July 24th. They issued a "market perform" rating for the company. Finally, CJS Securities assumed coverage on shares of Hawkins in a report on Tuesday, April 1st. They issued a "market outperform" rating and a $125.00 target price for the company.

Check Out Our Latest Analysis on Hawkins

Hawkins Company Profile

(Free Report)

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.

Read More

Institutional Ownership by Quarter for Hawkins (NASDAQ:HWKN)

Should You Invest $1,000 in Hawkins Right Now?

Before you consider Hawkins, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hawkins wasn't on the list.

While Hawkins currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines